Co-Organizers

Hayley Gans photo

Hayley Gans, MD

Hayley Gans, MD, is a professor of pediatrics at Stanford University Medical Center. She spends her clinical time on the pediatric infectious diseases service and co-directs the Pediatric Infectious Diseases Program for Immunocompromised Hosts. She is also the director of fellowship education for the Department of Pediatrics and the associate program director for the Pediatric Infectious Diseases Program. The focus of her research has involved investigations into the innate and adaptive immunity to viral vaccines in several different populations. Initial studies included infants receiving an early measles vaccination regimen, which then expanded to include preterm infants, HIV-infected adults and children, and children and adults undergoing liver and renal transplantation. In addition, studies also included an expanded repertoire of viral antigens, such as cytomegalovirus, poliovirus, varicella, and mumps. Recently, she has expanded her research to address viral infections in pediatric solid organ transplant recipients. Additional research efforts are directed at bioinformatics in immunocompromised cohorts and outcome measures in ambulatory pediatrics, as well as studies in the arena of medical education.

Tanvi Sharma photo

Tanvi S. Sharma, MD, MPH

Tanvi Sharma, MD, MPH is co-director of the immunocompromised hosts infectious diseases (ID) service and co-director of ID in the Pediatric Transplant Center at Boston Children’s Hospital. She is an assistant professor of pediatrics at Harvard Medical School. Dr. Sharma serves as the associate chief and clinical director within the division of pediatric ID, and also serves as director of the pediatric ID fellowship program at Boston Children’s Hospital. Dr. Sharma completed her medical training, residency in pediatrics, and fellowship in pediatric ID at University of Miami/Jackson Memorial Medical Center. She joined the faculty with the divisions of pediatric ID/immunology and pediatric clinical research at the University of Miami before moving to Boston. Her early research interests focused on metabolic complications in children with perinatally-acquired HIV infection receiving antiretroviral therapy, and have since evolved to evaluating infectious outcomes in children undergoing solid organ and hematopoietic stem cell transplantation. As both an educator and clinician caring for children with immunocompromising conditions, Dr. Sharma has additionally take on an active role in the development of curricula and training experiences focused on pediatric immunocompromised hosts infectious diseases. Dr. Sharma serves as co-chair for the Pediatric Infectious Diseases Society (PIDS) transplant ID subcommittee and serves as chair of the American Society of Transplantation (AST) ID Community of Practice Pediatrics Working Group which is leading a collaborative effort with PIDS to develop interactive educational modules specifically for pediatric transplant ID clinicians. Dr. Sharma also serves on the PIDS Education Committee and has previously served on the PIDS Training Program Directors Committee.

Elaine I. Tuomanen

Elaine I. Tuomanen

Elaine I. Tuomanen, MD, CM, is the ALSAC Endowed Chair of Infectious Diseases at St. Jude Children’s Research Hospital in Memphis, Tennessee. She is also director of the Children’s Infection Defense Center at St. Jude and adjunct professor of pediatrics and molecular sciences at the University of Tennessee.

After receiving her medical degree from McGill University, she served as pediatric intern and resident at Montreal Children’s Hospital. Dr. Tuomanen began her pediatric infectious diseases fellowship training at the University of Virginia in Charlottesville and completed her training as the Bristol Fellow of Infectious Diseases and the Parker B. Francis Pulmonary Research Fellow at Rockefeller University, where she began her work on Streptococcus pneumoniae pathogenesis under the mentorship of Dr. Alexander Tomasz. While an associate professor at Rockefeller University, she headed the Laboratory of Molecular Infectious Diseases, where she continued her groundbreaking work on the interplay between pneumococci and innate immunity. Among her seminal contributions are studies that link pneumococcal virulence factors to specific host receptors, the inflammatory bioactivities of cell wall, and the increased susceptibility of children with sickle cell disease to pneumococcal disease. Her work has been continuously funded by the National Institutes of Health for 30 years, and she is the author of over 200 peer-reviewed publications and over 100 reviews and book chapters.

In recognition of her impact on medical sciences, Dr. Tuomanen was elected a member of the Association of American Physicians and fellow of the American Academy for Microbiology. She was the recipient of the 1998 Maxwell Finland Award from Infectious Diseases Society of America, the 1997 E. Mead Johnson Award for Outstanding Research in Pediatrics from the American Academy of Pediatrics and the inaugural Pediatric Infectious Diseases Society (PIDS) Distinguished Research Award in 2014.

Dr. Tuomanen has devoted many years to understanding the mechanisms by which Streptococcus pneumoniae invades the human host, establishes infection, and manifests as invasive disease. In recent work, she and her research group have identified the molecular mechanisms by which S. pneumoniae access the cerebrospinal fluid and have developed vaccine antigens that protect against S. pneumoniae colonization, pneumonia, and meningitis. In addition, she has demonstrated a strong commitment to educating and mentoring the research efforts of our younger colleagues as the founder of the annual St. Jude-PIDS ID Research Conference, initiating the St. Jude-PIDS Transplant ID Symposium, and creating the PIDS-St. Jude Fellowship Award in Basic Science.

Speakers/Moderators

More bios coming soon

 Upton D. Allen - photo

Upton D. Allen, O.Ont, MBBS, MSc, FAAP, FRCPC, Hon FRCP (UK), FIDSA

Upton D. Allen, O.Ont, MBBS, MSc, FAAP, FRCPC, Hon FRCP (UK), FIDSA, is a Professor of Paediatrics at the University of Toronto. He is Chief, Division of Infectious Diseases, Hospital for Sick Children. He is interim director of the Transplant and Regenerative Medicine Centre, Hospital for Sick Children. Dr. Allen is a Senior Associate Scientist in the Research Institute, Hospital for Sick Children. His primary appointment is with the Division of Infectious Diseases, Department of Paediatrics at the Hospital for Sick Children. He is cross-appointed as a professor in the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Allen received his medical degree from the University of the West Indies, Kingston, Jamaica. He received pediatric training at the Hospital for Sick Children, Toronto. He obtained further research training leading to a degree in Clinical Epidemiology (MSc) from McMaster University.

Dr. Allen is a past director of the Infectious Diseases Society of America and Fellow of the Society. He is a Fellow of the American Academy of Pediatrics, Fellow of the Royal College of Physicians and Surgeons of Canada and Fellow of the Royal College of Physicians (UK). He is a past Chair of the Infectious Diseases Specialty Training Committee, Royal College of Physicians and Surgeons of Canada (RCPSC). Past awards include the Clinical Science Established Investigator Award from the American Society of Transplantation. In 2018, he was awarded the Order of Ontario, which is the highest honor awarded by the province of Ontario, Canada.

In addition to being a general infectious diseases specialist, he is actively involved in clinical and research activities relating to immunocompromised patients, notably those who have undergone organ and stem cell transplantation as well as cancer therapies. He has a major research interest in Epstein-Barr virus-related post-transplant lymphoproliferative disorder (PTLD) as well as an interest in respiratory syncytial virus infections. Dr. Allen has had many academic and professional accomplishments. He has had numerous invited lectures internationally, visiting professorships, greater than 300 scientific publications, several book chapters, more than 190 scientific abstracts and several peer-reviewed research grants.

Hamid Bassiri, MD, PhD  - photo

Hamid Bassiri, MD, PhD

Dr. Bassiri completed his Ph.D. in Immunology and his M.D. at the Perelman School of Medicine at the University of Pennsylvania (Penn). He then pursued a residency in General Pediatrics and a fellowship in pediatric infectious diseases at the Children’s Hospital of Philadelphia (CHOP). He was appointed as an Assistant Professor at Penn in 2013, and now provides pediatric infectious disease consultations at CHOP, where he specializes in the care of immunocompromised children. As a faculty member at the Center for Childhood Cancer Research, his current laboratory research focuses on delineating the immunometabolic features of invariant natural killer T (iNKT) cells, and defining strategies to co-opt the immunotherapeutic functions of these cells and those of NK cells in the neuroblastoma tumor microenvironment. Finally, at CHOP he also serves as the Associate Program Director for the Pediatric Infectious Diseases fellowship program, an Assistant Director for the Clinical Immunology laboratory, and a member of the Dysregulated Immunity consultation team.

Catherine Bollard, MBChB, MD, FRACP, FRCPA  - photo

Catherine Bollard, MBChB, MD, FRACP, FRCPA

Catherine Bollard received her medical degree at the University of Otago in Dunedin, New Zealand. She is Board certified both in Pediatrics and Hematology. She worked in New Zealand and London, England before moving to Houston in 2000 where she was Professor of Pediatrics, Medicine and Immunology at Baylor College of Medicine (BCM) and Director of the Texas Children’s Cancer and Hematology Center Pediatric Lymphoma Program. In August 2013, she moved to Washington DC to join Children’s National Health System and The George Washington University School of Medicine and Health Sciences. She is currently the Bosworth Chair for Cancer Biology, Director of the Center for Cancer and Immunology Research, and Director of the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children’s National Health System. She is a Professor of Pediatrics and of Microbiology, Immunology and Tropical Medicine at The George Washington University and Associate Center Director for Translational Research and Innovation at the GW Cancer Center. She is a member of the American Society for Clinical Investigation (ASCI) and is the immediate Past President of the International Society for Cellular Therapy (ISCT) and has chaired the Non Hodgkin Lymphoma (NHL) Committee of the Children’s Oncology Group since 2012. She was on the Board of Directors of the Foundation in for the Accreditation of Cellular Therapy (FACT) from 2010-2018 and was a member of the Cellular, Tissues and Gene Therapies Advisory Committee of the Food and Drug Administration (FDA) from 2015-2019. In 2019 she became a member of the Frederick National Laboratory Advisory Committee (FNLAC) for the NIH and an ad hoc member of the Pediatric Oncologic Drugs Advisory Committee (ODAC) for the FDA. She has been an Associate Editor for the journal Blood since 2014 and recently completed her six year term on NCI’s Clinical Oncology (CONC) Study Section. Her bench and translational research focuses on improving outcomes for patients after hematopoietic stem cell transplantation and on the development of novel cell therapies for viral diseases and hematologic malignancies.

Daniel E Dulek, MD - photo

Daniel E Dulek, MD

Daniel E Dulek, MD is an Assistant Professor in Pediatric Infectious Diseases at Vanderbilt University Medical Center and the Monroe Carell Jr. Children’s Hospital at Vanderbilt. He is medical director of the Immunocompromised Pediatric Infectious Diseases Service at Vanderbilt Children’s and, as such, works closely with transplant teams in both clinical care and research programs. Dr. Dulek is experienced in clinical research in transplant populations through work in viral epidemiology studies as well as vaccine trials. He has a specific research interest in immunologic prediction of viral infection risk in pediatric transplant recipients.

Brian T. Fisher, DO, MSCE - photo

Brian T. Fisher, DO, MSCE

Bio coming soon.

Michael Green, MD, MPH - photo

Michael Green, MD, MPH

Michael Green, MD, MPH, is Professor, Pediatrics, Surgery, and Clinical and Translational Science, at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Illinois in Chicago and his master’s degree from the University of Pittsburgh in Pennsylvania. He completed a pediatric residency and a fellowship in pediatric infectious diseases at Children’s Hospital of Pittsburgh.

Throughout his career, Dr. Green’s clinical and research interest have focused on the prevention and treatment of infections in immunocompromised children with a particular interest in the care of children undergoing solid organ transplantation. Among his professional affiliations, Dr Green is a member of the Pediatric Infectious Disease Society, the American Pediatric Society, the Infectious Diseases Society of America, the International Pediatric Transplant Association, and the American Society of Transplantation (AST). Dr Green has published more than 160 peer-reviewed articles, has been invited to author over 45 publications, and has written more than 75 review articles or textbook chapters. He serves as an Associate Editor for both Pediatric Transplantation and the Journal of the Pediatric Infectious Disease Society. He was co-editor of the First Edition of the Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation published by the American Society of Transplantation and was the Editor-in-chief for the recently published 4th edition the guidelines which were published in 2019. He currently serves on the Pediatric Infectious Diseases Sub board of the American Board of Pediatrics and is a member of the FDA Antimicrobial Advisory Committee. He has participated in numerous Consensus Conference and Guideline working groups relating to the field of transplant infectious diseases and previously served as the chair for the OPTN/UNOS ad hoc Disease Transmission Advisory Committee. An active teacher and clinical researcher, Dr Green has been invited to present his work at national and international conferences, and has consistently received grant funding for his work since 1987.

Stephan Grupp, MD PhD - photo

Stephan Grupp, MD PhD

Stephan Grupp, MD PhD, is the Chief of the Cellular Therapy and Transplant Section, Director of the Cancer Immunotherapy Program, and Medical Director of The Cell and Gene Therapy Lab at the Children’s Hospital of Philadelphia (CHOP), as well as the Yetta Dietch Novotny Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine. Dr. Grupp graduated from the University of Cincinnati after completing the MD/PhD program with a PhD in Immunology. He completed pediatric residency at the Boston Children’s Hospital, followed by a fellowship in Pediatric Hematology/Oncology at the Dana Farber Cancer Institute and postdoctoral work in Immunology at Harvard University. He then joined the faculty at Harvard University until 1996, when he came to CHOP. His primary area of clinical research is the use of CAR T and other engineered cell therapies in relapsed pediatric cancers. He led all of the pediatric ALL trials of CTL019 (now approved as Kymriah), including the largest and most successful engineered T cell therapy clinical trial conducted to date (1, 2), as well as the global registration trial for CTL019 (3). As a result of this work, he presented the Clinical Perspective at the July 2018 FDA ODAC meeting, at which reviewers voted 10-0 for recommendation of approval for Kymriah in pediatric ALL. His primary laboratory interest is the development of new cell therapy treatments for pediatric cancers. Dr. Grupp was elected to the National Academy of Medicine in 2019. Dr. Grupp is a reviewer for several journals and the author of over 200 peer-reviewed journal articles, as well as numerous abstracts and book chapters.

Natasha Halasa, MD, MPH - photo

Natasha Halasa, MD, MPH

Natasha Halasa, MD, MPH is Associate Professor in the Division of Pediatric Infectious Diseases at Vanderbilt University. She received a Bachelor of Science degree with a major in biology from the University of Akron. She received her M.D. degree from the Medical College of Ohio and completed a residency in pediatrics at Columbus Children’s Hospital. She completed a fellowship in pediatric infectious diseases at Vanderbilt and earned an M.P.H. degree during her fellowship training. She joined the faculty in 2004. Dr. Halasa’s research involves determining the burden of diarrheal and respiratory illnesses in young children and specialized populations and finding ways to reduce their burden (e.g. through vaccine, drugs, etc…). Since 2002, Dr. Halasa has been involved in vaccine trials enrolling children from all ages, including young infants and specialized populations such as children with cancer. The vaccine trials that Dr. Halasa has been involved with in the past include influenza vaccines (both the trivalent inactivated influenza vaccine and the cold-adapted influenza vaccine), pertussis vaccines, pneumococcal, and RSV vaccines. In addition, she has the expertise in vaccine protocol development. She was the PI of a respiratory viral surveillance study in Amman, Jordan, which was funded Union Bank of Switzerland. Currently, currently is PI of the Vanderbilt site of the New Vaccine Surveillance Network initially established in 1999 by the U.S. Centers for Disease Control and Prevention (CDC) to predict the impact of potential new vaccines and two NIH grants investigating high dose influenza vaccine versus standard dose influenza vaccine in pediatric and adult stem cell recipients.

Benjamin Hanisch - photo

Benjamin Hanisch

Dr. Hanisch is an assistant professor in pediatrics at George Washington University with appointments in pediatric infectious disease and blood and marrow transplant divisions at Children’s National Medical Center in Washington DC. His clinical and research interests are in infections in immunocompromised children.

Betsy Herold, MD - photo

Betsy Herold, MD

Bio coming soon.

Jennifer Hidinger, MD - photo

Jennifer Hidinger, MD

Jennifer Hidinger, MD is a first year Infectious Disease fellow at St. Jude Children’s Research Hospital. She received her medical degree from the University of Tennessee College of Medicine and then completed a residency in General Pediatrics at Le Bonheur Children’s Hospital. Dr. Hidinger’s research focus is developing, but she has an interest in immunocompromised hosts.

Ashish Kumar - photo

Ashish Kumar

Dr. Kumar received his medical degree from L.T.M. Medical College, Mumbai, India, his PhD in anatomy and cell biology from the University of Iowa, pediatric residency training at the Mayo Clinic and fellowship in pediatric hematology / oncology / BMT at the University of Minnesota. He is currently a professor of pediatrics at the University of Cincinnati College of Medicine in the Division of Bone Marrow Transplantation and Immune Deficiency at Cincinnati Children's Hospital Medical center. Dr. Kumar’s laboratory research has focused on infant leukemia, and Langerhans Cell Histiocytosis. He is the director of the LCH center, and a key member of the HLH center at Cincinnati Children’s. He is also the director of pediatric hematology-oncology fellowship training program.

Gabriela Maron - photo

Gabriela Maron

Gabriela Maron, MD (Gaby) completed Medical School and Pediatrics residency in her home country of El Salvador, where she was also Chief Resident. She then came to Memphis for a Fellowship in Pediatric Infectious Diseases, at the joint program of the University of Tennessee Health Science Center, Le Bonheur Children’s Medical Center, St. Jude Children’s Research Hospital, Memphis, TN. She did an additional year of fellowship in pediatric and adolescent HIV and completed a Masters in Clinical Epidemiology. Following fellowship she returned to El Salvador where she worked as the ID physician for the national pediatric HIV clinic and the ID consultant for the national oncology program. She returned to St. Jude in 2013 and has since worked as the ID consultant embedded in the Department of Bone Marrow Transplantation and Cellular Therapy. Her current research interests include infections in transplant patients and the association of the microbiome with outcomes in HCT patients.

William Muller, MD, PhD - photo

William Muller, MD, PhD

William Muller: My primary clinical interest is in infections in immunocompromised patients, including stem cell and solid organ transplant recipients. I am involved in numerous clinical trials involving anti-infectives, in both the immunocompromised population and in situations involving other pediatric infections. I also study the pathogenesis of viral encephalitis, using models which focus on host-pathogen interactions in neurologic disease due to herpes simplex virus in newborns.

Flor Muñoz, MD - photo

Flor Muñoz, MD

Flor Muñoz, MD, is Associate Professor of Pediatrics and Infectious Diseases at Baylor College of Medicine, and Director of Transplant Infectious Diseases at Texas Children’s Hospital in Houston, TX. She is a clinician-investigator with various projects supported by the US NIH, CDC, BMGF or industry, focusing on vaccines, the epidemiology of respiratory infections in healthy and immunocompromised hosts, and the evaluation of safety and immunogenicity of vaccines in pregnant women, children, and transplant recipients. She has published extensively on topics related to influenza, RSV, vaccines, and maternal immunization. Dr Muñoz is a member of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases (COID), the CDC’s Advisory Committee on Immunization Practices (ACIP) influenza and pertussis working groups, and the American College of Obstetrics and Gynecology (ACOG) Immunization Expert Work Group. Dr. Munoz serves as chair of the Institutional Review Board (IRB) at Baylor College of Medicine, and is a member of various academic societies, including the Pediatric Infectious Diseases Society (PIDS), the Society for Pediatric Research (SPR), the Research Committee of the European Society of Pediatric Infectious Diseases, and the PIDS Transplant Group.

Anoma Nellore - photo

Anoma Nellore

Dr. Nellore is Assistant Professor of Infectious Diseases and Associate Medical Director of the Immunocompromised Infectious Diseases Program at the University of Alabama at Birmingham.

Caitlin Newhouse, MD - photo

Caitlin Newhouse, MD

Caitlin Newhouse, MD is a Fellow in Pediatric Infectious Diseases and Preventive Medicine at Mattel Children’s Hospital at UCLA. She received her medical degree at Georgetown University School of Medicine and completed residency at Children’s Hospital Los Angeles. Her research interests are in health services research related to global and public health, infection prevention, antibiotic stewardship and HIV.

William R. Otto, MD - photo

William R. Otto, MD

William Otto, MD is a second-year fellow in Pediatric Infectious Diseases at the Children's Hospital of Philadelphia. He completed medical school at the Saint Louis University School of Medicine in St. Louis, MO before completing his residency in pediatrics at Children's Mercy Hospital in Kansas City, MO. His research focuses on the clinical epidemiology of infectious diseases in immunocompromised children, particularly oncology patients and hematopoietic stem cell transplant recipients.

Chiaki Kidoguchi - photo

Chiaki Tao-Kidoguchi, MD

Chiaki Tao-Kidoguchi, MD is a clinical fellow in the Division of Infectious Diseases at the National Center for Child Health and Development. Her specific research interests are immune response to vaccines and immune reconstitution after hematopoietic stem cell and solid organ transplantation.

Taylor Treadway - photo

Taylor Treadway

Taylor Treadway is an undergraduate student at the University of Wisconsin-Madison majoring in neurobiology and psychology. She has been working under the mentorship of Dr. Emma Mohr for one year, studying the tissue tropism of Zika virus RNA in a pregnant, rhesus macaque model. She plans to pursue a career in the health sciences or a PhD in translational research.

Nava Yeganeh - photo

Nava Yeganeh

Dr. Yeganeh is an Assistant Professor in the Department of Pediatrics, Division of Infectious Disease at the David Geffen School of Medicine at UCLA. She obtained a medical degree at University of Washington School of Medicine, a Master of Public Health at Johns Hopkins School of Public Health, and has been at UCLA since 2005, completing her training as a board certified pediatrician and pediatric infectious disease physician. Her current NIH-supported research focuses on preventing the transmission of HIV and other sexually transmitted infections (STIs) to infants through the implementation of an initiative offering testing for STIs to partners of pregnant women. This project is currently enrolling patients at sites in South Brazil, with an aim to protect mothers from infection during the vulnerable time of pregnancy. She has been collaborating with sites in Brazil since 2010, evaluating HIV and other STIs in vulnerable populations, and have worked extensively with collecting and analyzing data collected during large trials including the HPTN 040/IMPAACT 1043 trial. She has also been the Pediatric Infectious Disease Fellowship Director since 2018 and the Program Director for the International Travel and Adoption Clinic at Mattel’s Children Hospital since 2015. She is an attending on the Pediatric Infectious Disease service, focusing her clinical time caring for transplant and immunocompromised children.

Inci Yildirim, MD, PhD, MSc - photo

Inci Yildirim, MD, PhD, MSc

Inci Yildirim, MD, PhD, MSc is an Assistant Professor of Pediatric Infectious Diseases and Epidemiology at Emory University School of Medicine and Rollins School of Public Health, and Director of Transplant Infectious Diseases at Emory-Children’s Healthcare of Atlanta in Atlanta, GA. She is a clinical trialist and vaccinologist with specific research interest in immune response to vaccines and immune reconstitution after hematopoietic stem cell and solid organ transplantation.

7th Annual St. Jude/PIDS
Transplant and Immunocompromised Hosts ID Symposium:
Bench to Bedside Preliminary Program at a Glance

Wednesday, March 11

6:00-8:00 p.m. Meet the Experts (new) and Satellite Registration – Westin/Tennessee Ballroom
  • How to develop a career in Transplant ID
  • APP roles in Transplant ID
  • The role of ASP and pharmacist in Transplant ID
  • The future of scholarship in ID in IC

Thursday, March 12

7:00 a.m. Breakfast
7:45-8:00 a.m. Welcome and Announcements
8:00-9:00 a.m. Grand Rounds
Clinical Perspective and Significance of CAR-T cell Therapy in Children: What is the Future?
Updates Two Years after FDA Approval
Stephan Grupp, MD, Children’s Hospital of Philadelphia
9:00-9:45 a.m. HLH updates and innovations
"It's a Bird..It's a Plane..It's Super-mac!"
Ashish Kumar, MD, Cincinnati Children’s Hospital Medical Center
BREAK (9:45-9:55 a.m.)
Research Updates
9:55-10:25 a.m.

Oral Abstract:  Modeling Zika virus tissue tropism in rhesus macaques to define the risk of donor derived transmission
Taylor Treadway, Student, University of Wisconsin - Madison

Oral Abstract: Safety of Live Attenuated Vaccines Administered after Pediatric Liver Transplantation
Chiaki Tao-Kidoguchi, MD, National Center for Child Health and Development

PIDS/St Jude Transplant ID Research in Progress
10:25-10:50 a.m.

CMV T cell Immunity Study Update

Daniel Dulek, MD, Vanderbilt University

PIDTRAN Research Update
Gabriela Maron, MD, St. Jude Children’s Research Hospital

CMV-specific T cell Immunity in Pediatric Solid Organ Transplantation Study Update
Daniel Dulek, MD, Vanderbilt University

FDA Proposal Update: Incidence and Outcomes of Human Adenovirus Infection and Disease Among a Multicenter Observational Cohort of Pediatric Hematopoietic Cell Transplant Recipients
Brian T. Fisher, DO, MSCE, Children’s Hospital of Philadelphia

Platform Presentations
10:55-11:40 a.m. Virus specific T cells after Bone Marrow Transplant: Broadening Applicability
Catherine Bollard, MD, Children’s National Medical Center
11:40-12:25 p.m. "B-sides": Novel Correlates of Immune Responses to Vaccination
Anoma Nellore, MD, University of Alabama at Birmingham
LUNCH PICK UP (12:25 – 12:35 p.m.)
Cases Conferences (30 minutes each)
12:35-1:05 p.m. Challenging Cases in HSCT and Other Oncology Patients
Gabriela Maron, MD, St. Jude Children’s Research Hospital
Hamid Bassiri, MD, Children’s Hospital of Philadelphia
1:05-1:35 p.m. Challenging Cases in SOT Recipients
Flor Munoz-Rivas, MD, Texas Children’s Hospital
Benjamin Hanisch, MD, Children’s National Medical Center
1:35-2:05 p.m. Challenging Cases in Other Immunocompromised Hosts
William Muller, MD, PhD, Lurie Children’s Hospital of Chicago
Natasha Halasa, MD, MPH, Vanderbilt Pediatrics, Nashville
BREAK (2:05-2:15 p.m.)

Platform Presentations
2:15-3:00 p.m.

Update on Viral infections in Solid Organ Transplant Patients

"Major Viral Infections in Solid Organ Transplant Patients: An Update"
Upton Allen, MD, Hospital for Sick Kids

3:00-3:45 p.m. Drug Resistant Bacterial Infections in Pediatric Transplant Patients: A Growing Challenge
Gabriela Maron, MD, St. Jude Children’s Research
Ask the Panelists
3:45-4:30 p.m. Drs. Stephan Grupp, Ashish Kumar, Anoma Nellore, Upton Allen, and Gabriela Maron
BREAK (4:30-4:45 p.m.)
4:45-6:00 p.m. Posters with Professors

Early Registration Fees (Deadline: 01/11/2019)

Fellows, Residents, Students Free
PIDS Members $55.00
Non-Members $135.00

General Registration Fees (01/12/2019 - 02/19/2019)

Fellows, Residents, Students Free
PIDS Members $75.00
Non-Members $190.00

On-site Registration Fees Begin 2/20/2019

Fellows, Residents, Students Free
PIDS Members $100.00
Non-Members $245.00 

Hotel Information

Hotel accommodations are available at the Westin Memphis Beale Street located at 170 Lt. George W. Lee Ave, Memphis TN 38103. A one night's deposit is required for ALL reservations. 

Any reservations made after 5:00pm CST on February 19, 2019 will be charged the regular hotel rate. Reservations must be guaranteed with an individual or company credit card at time of booking.

Room rate: $195/night

Click here to reserve your room.

Cancellations

In the event of an individual cancellation less than 72 hours prior to arrival, a cancellation fee of one night's room and tax will be charged. A cancellation number must be secured by the guest and will be the only acceptable proof that the reservation was cancelled.

The 2017 St. Jude Children's Research Hospital and PIDS' Pediatric Transplant ID Symposium will be held on Thursday, March 9, 2017 at the St. Jude Children’s Research Hospital in Memphis, Tennessee.

Target Audience:

Fellows and faculty in pediatric infectious diseases and transplantation medicine as well as other healthcare providers with an interest in transplant ID.

Objectives:

  • Update on current diagnosis, treatment and management of opportunistic infections and other complications associated with pediatric transplantation including CMV, fungal infections, and thrombotic microangiopathy.
  • Understand the role of immunotherapies including T cell therapies, microbiome and age on transplant outcomes and infectious complications.
  • Research gaps in transplant ID.
  • Understand how different immunosuppressive agents predispose to specific infectious diseases.

Topics

  • Overview of Transplant Immunology
  • Microbiome and GVHD
  • T cell Therapies
  • Surgical Aspects of Transplantation
  • NIAID Funding
  • Thrombotic Microangiopathy
  • CMV Antivirals
  • Impact of Age on Transplant
  • Fungal Management (Monotherapy v Multiple Agents)
  • Transplant Research

Registration/Housing

The online registration period has closed; onsite registration will be available at the registration desk. Please contact PIDS Headquarters with any questions or changes to your registration at 703-299-6764 or This email address is being protected from spambots. You need JavaScript enabled to view it.. Click here for more information on registration and housing.

Program

Click here to view the program.

Abstract & Case Submissions

The Pediatric Infectious Diseases Society (PIDS) and St. Jude Children's Research Hospital are pleased to open the abstract and case submission period. Please submit abstracts and cases by January 13, 2017 to be considered for presentation at the Pediatric Transplant ID Symposium. Click here to submit your presentations online.

2020 St. Jude / PIDS Pediatric Transplant ID Symposium March 12, 2020 banner

 

Dear All –

 

St Jude and PIDS leadership have made the difficult decision to cancel the upcoming St. Jude/PIDS Conference due to the increasing spread of COVID-19.   This decision was made after several days of deliberation with the conference organizers, PIDS leadership, and the St. Jude Infection Prevention Team.  Out of an abundance of caution, we want to avoid unnecessary exposures to the immunocompromised children of St. Jude; moreover, there is simply no effective way to rapidly screen for the virus and attendees will be travelling from international and national sites, which further confuses risk calculation. 

 

We know that this decision will affect you all in a number of ways, but we trust that you understand that this is an evolving issue that requires utmost caution. For those who submitted abstracts for presentation, please know that we still plan to publish these in their entirety in an upcoming issue of JPIDS. If you have any other questions or concerns, please feel free to reach out to our PIDS staff at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

PIDS will continue to update our membership on COVID-19 developments. We wish you all the best as you care for your local communities and advance research on this and other microbes that threaten pediatric health.

 

Onward and upward,

Elaine and Buddy

 

 

 

 

The 2020 St. Jude Children's Research Hospital and PIDS' Pediatric Immunocompromised Hosts and Transplant ID Symposium: Bench to Bedside will be held on Thursday, March 12, 2020 at the St. Jude Children’s Research Hospital in Memphis, Tennessee.

The meeting will feature leaders in the field presenting cutting edge information relevant to the immunocompromised host including CAR-T cell therapies, hemophagocytic lymphohistiocytosis, viral specific T cell therapy, updates on viral infections and immunizations in solid organ transplant recipients, and antimicrobial resistance in immunocompromised hosts. Interactive breakout sessions will highlight challenging cases and focus on current diagnosis, treatment and management of infectious complications in pediatric patients with immunocompromising conditions or those undergoing transplantation. Research updates will be featured throughout the day, through presentations and poster sessions. Participants will have the opportunity to interact with experts on the day of the symposium through a panel Q&A and the evening preceding the symposium through roundtable sessions to informally discuss research opportunities, careers in transplant infectious diseases, and the role of pharmacists and advanced practice providers in the care of immunocompromised patients.

Target Audience:

Fellows and faculty in pediatric infectious diseases and transplantation medicine as well as other healthcare providers with an interest in transplant ID and immunocompromised hosts.

Objectives:

  • Update on current diagnosis, treatment and management of infectious complications pediatric immunocompromised patients.
  • Understand advances in viral infections, T cell therapies and management of HLH.
  • Appreciate prevention of viral disease through T cell transfer and vaccination.
  • Consider research gaps in transplant ID.
  • Understand the impact of antimicrobial resistance in immunocompromised hosts.

Registration/Housing

Program

Biographies

Abstract Submissions

Call for Cases

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children’s Research Hospital and the Pediatric Infectious Diseases Society. St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.